VOL. XCIV, NO. 247
WIDE MOAT STOCKS COMPARISON
Stock Comparison
Becton, Dickinson and Company vs Danaher Corporation
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Becton, Dickinson and Company
BDX · New York Stock Exchange
Partial score covering 71% of segment weight.
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Becton, Dickinson and Company's moat claims, evidence, and risks.
View BDX analysisDanaher Corporation
DHR · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Danaher Corporation's moat claims, evidence, and risks.
View DHR analysisComparison highlights
- Segment focus: Becton, Dickinson and Company has 4 segments (34.7% in Medical Essentials); Danaher Corporation has 3 segments (39.4% in Diagnostics).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Weak vs Moderate.
- Moat breadth: Becton, Dickinson and Company has 5 moat types across 2 domains; Danaher Corporation has 5 across 3.
Primary market context
Becton, Dickinson and Company
Medical Essentials
Single-use medical consumables and specimen collection systems
Global
Healthcare providers and clinical labs
Manufacturer
34.7%
Danaher Corporation
Diagnostics
In vitro diagnostics instruments, consumables, software, services and acute-care patient monitoring
Global
Hospitals, physician offices, reference laboratories, pathology labs, critical care settings
IVD device manufacturer, reagent/test supplier, patient-monitoring technology provider + software/services
39.4%
Side-by-side metrics
Moat coverage
Shared moat types
Becton, Dickinson and Company strengths
Danaher Corporation strengths
Segment mix
Becton, Dickinson and Company segments
Full profile >Medical Essentials
Competitive
Connected Care
Oligopoly
BioPharma Systems
Oligopoly
Interventional
Competitive
Danaher Corporation segments
Full profile >Biotechnology
Oligopoly
Life Sciences
Oligopoly
Diagnostics
Oligopoly
Act on this comparison
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.